back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-11-19 11:41 Tx date 2024-11-14 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,550
-710,000 vol $0.005 each |
696,000 | |
| Filed 2024-09-30 10:12 Tx date 2024-09-25 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,270 vol |
1,480,270 | |
| Filed 2024-07-03 12:50 Tx date 2024-06-28 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+645,089 vol |
1,610,089 | |
| Filed 2024-07-03 12:48 Tx date 2024-06-28 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$14,492
+322,061 vol $0.045 each |
322,061 | |
| Filed 2024-07-03 12:46 Tx date 2018-09-18 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-05-03 14:25 Tx date 2024-04-29 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$502,000
+1,255,000 vol $0.40 each |
1,405,000 | |
| Filed 2024-03-19 14:57 Tx date 2024-03-18 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+875,000 vol |
875,000 | |
| Filed 2024-03-19 14:53 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-19 14:53 Tx date 2024-03-18 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares catégorie A
11 - Acquisition or disposition carried out privately
|
$350,000
+875,000 vol $0.40 each |
875,000 | |
| Filed 2024-03-19 14:51 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-14 09:49 Tx date 2023-11-09 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$63,000
+350,000 vol $0.18 each |
350,000 | |
| Filed 2023-11-14 09:48 Tx date 2018-09-18 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-14 09:47 Tx date 2023-11-09 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
965,000 | |
| Filed 2023-09-28 10:42 Tx date 2023-09-25 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
+350,000 vol |
1,406,000 | |
| Filed 2023-09-28 10:40 Tx date 2023-09-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
38 - Redemption, retraction, cancellation, repurchase
|
+650,000 vol |
2,648,055 | |
| Filed 2023-09-14 17:57 Tx date 2023-09-13 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,750
+65,000 vol $0.35 each |
1,477,500 | |
| Filed 2023-08-18 15:45 Tx date 2023-08-18 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$32,000
+100,000 vol $0.32 each |
1,998,055 | |
| Filed 2023-05-09 16:45 Tx date 2023-05-01 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-708,000 vol |
0 | |
| Filed 2023-05-09 16:43 Tx date 2023-05-01 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 10%, Exp May 1 2023, $0.20 Conversion Price
38 - Redemption, retraction, cancellation, repurchase
|
-$354,000 vol |
$0 | |
| Filed 2023-05-09 16:35 Tx date 2023-05-04 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+2,360,000 vol |
3,616,678 | |
| Filed 2023-05-09 16:34 Tx date 2023-05-04 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants May 4, 2023 ($0.35) 36mo.
16 - Acquisition or disposition under a prospectus exemption
|
$826,000
+2,360,000 vol $0.35 each |
2,360,000 | |
| Filed 2023-05-09 16:32 Tx date 2018-09-18 |
$CHGX
CHITOGENX INC |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants May 4, 2023 ($0.35) 36mo.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-17 12:05 Tx date 2023-03-15 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$198,000
+300,000 vol $0.66 each |
1,412,500 | |
| Filed 2023-03-04 06:33 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2023-03-03 16:48 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
||
| Filed 2023-03-03 16:48 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2023-03-03 07:12 Tx date 2023-02-22 |
$LSL
LSL Pharma Group Inc. |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-31 07:22 Tx date 2023-01-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
56 - Grant of rights
|
$100,000
+178,572 vol $0.56 each |
178,572 | |
| Filed 2023-01-31 07:19 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-06-02 11:46 Tx date 2022-06-02 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,500
+100,000 vol $0.195 each |
1,056,000 | |
| Filed 2022-04-30 09:40 Tx date 2022-04-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,750
+37,500 vol $0.66 each |
1,112,500 | |
| Filed 2022-04-11 15:16 Tx date 2022-04-05 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Notes Convertible unsecured, 10%, 12 months
38 - Redemption, retraction, cancellation, repurchase
|
$
-$25 vol $1,000 each |
$0 | |
| Filed 2022-04-08 08:30 Tx date 2022-04-05 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants April 5, 2022 ($0.35) 24mo.
16 - Acquisition or disposition under a prospectus exemption
|
+879,178 vol |
879,178 | |
| Filed 2022-04-08 08:29 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants April 5, 2022 ($0.35) 24mo.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-08 08:26 Tx date 2022-04-05 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$175,835
+879,178 vol $0.20 each |
1,256,678 | |
| Filed 2021-12-15 09:06 Tx date 2021-12-13 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Notes Convertible unsecured, 10%, 12 months
11 - Acquisition or disposition carried out privately
|
$
+$25 vol $975.00 each |
$25 | |
| Filed 2021-12-14 14:37 Tx date 2021-12-13 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Notes Convertible unsecured, 10%, 12 months
11 - Acquisition or disposition carried out privately
|
$
+$2,500 vol $975.00 each |
||
| Filed 2021-12-14 14:41 Tx date 2021-12-13 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants December 13, 2021 ($0.50)
11 - Acquisition or disposition carried out privately
|
+25,000 vol |
25,000 | |
| Filed 2021-12-14 14:38 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants December 13, 2021 ($0.50)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-14 14:37 Tx date 2021-12-13 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Notes Convertible unsecured, 10%, 12 months
11 - Acquisition or disposition carried out privately
|
$
+$2,500 vol $975.00 each |
$2,500 | |
| Filed 2021-12-14 14:35 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Notes Convertible unsecured, 10%, 12 months
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-03 12:10 Tx date 2021-12-03 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,600
+135,000 vol $0.36 each |
377,500 | |
| Filed 2021-10-05 14:08 Tx date 2021-10-05 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$44,000
+50,000 vol $0.88 each |
393,000 | |
| Filed 2021-08-20 16:00 Tx date 2021-08-20 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,750
+50,000 vol $0.455 each |
956,000 | |
| Filed 2021-07-23 07:38 Tx date 2021-07-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$40,500
+67,500 vol $0.60 each |
1,898,055 | |
| Filed 2021-07-16 07:45 Tx date 2021-07-15 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$100,005
+150,000 vol $0.67 each |
1,830,555 | |
| Filed 2021-06-29 17:25 Tx date 2021-06-29 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants (29JUNE2024, $1.25)
15 - Acquisition or disposition under a prospectus
|
+200,000 vol |
200,000 | |
| Filed 2021-06-29 17:23 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants (29JUNE2024, $1.25)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-29 17:22 Tx date 2021-06-29 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$200,000
+200,000 vol $1.00 each |
343,000 | |
| Filed 2021-04-23 13:14 Tx date 2021-04-23 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$5,471
+4,800 vol $1.14 each |
143,000 | |
| Filed 2021-04-23 07:03 Tx date 2021-04-22 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+12,500 vol $0.48 each |
242,500 | |
| Filed 2021-04-22 06:24 Tx date 2021-04-21 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$10,710
+10,200 vol $1.05 each |
138,200 | |
| Filed 2020-12-04 12:49 Tx date 2020-12-02 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+30,000 vol |
130,000 | |
| Filed 2020-12-04 12:43 Tx date 2020-12-02 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Non-Convertible, Secured, 10%, 3 Years
11 - Acquisition or disposition carried out privately
|
$
+$60 vol $1,000 each |
$60 | |
| Filed 2020-12-04 12:41 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Non-Convertible, Secured, 10%, 3 Years
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-19 16:19 Tx date 2020-10-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+1,000 vol $0.60 each |
906,000 | |
| Filed 2020-09-14 11:19 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
15 - Acquisition or disposition under a prospectus
|
+12,500 vol |
12,500 | |
| Filed 2020-09-14 11:12 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants VPH.WT. A.(10SEP2022 Warrants)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 11:12 Tx date 2020-09-10 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$30,000
+25,000 vol $1.20 each |
1,680,555 | |
| Filed 2020-08-27 11:36 Tx date 2020-08-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+100,000 vol |
100,000 | |
| Filed 2020-08-26 11:16 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-26 11:15 Tx date 2020-08-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$32,000
+100,000 vol $0.32 each |
230,000 | |
| Filed 2020-07-13 15:51 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+82,500 vol |
701,000 | |
| Filed 2020-07-13 15:49 Tx date 2020-07-10 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption
|
+$55,000 vol |
$55,000 | |
| Filed 2020-07-13 15:43 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-07-01 16:43 Tx date 2020-06-30 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+100,000 vol $0.60 each |
1,075,000 | |
| Filed 2020-05-25 12:10 Tx date 2020-05-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$32,000
+80,000 vol $0.40 each |
1,655,555 | |
| Filed 2020-05-19 16:41 Tx date 2020-05-14 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$2,250
+25,000 vol $0.09 each |
618,500 | |
| Filed 2020-05-19 13:19 Tx date 2020-05-14 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$3,400
+40,000 vol $0.085 each |
593,500 | |
| Filed 2020-04-25 07:06 Tx date 2020-04-20 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,375
+5,000 vol $0.275 each |
130,000 | |
| Filed 2020-04-25 07:05 Tx date 2020-04-20 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,250
+25,000 vol $0.25 each |
125,000 | |
| Filed 2020-04-23 18:41 Tx date 2020-04-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$122,000
+244,000 vol $0.50 each |
708,000 | |
| Filed 2020-04-23 18:20 Tx date 2020-04-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
10 - Acquisition or disposition in the public market
|
$
+$122,000 vol $0.30 each |
$354,000 | |
| Filed 2020-04-16 15:28 Tx date 2020-04-16 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$40,000
+200,000 vol $0.20 each |
905,000 | |
| Filed 2020-02-19 15:02 Tx date 2020-02-19 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$7,440
+16,000 vol $0.465 each |
128,000 | |
| Filed 2020-02-19 15:01 Tx date 2020-02-18 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$5,580
+12,000 vol $0.465 each |
112,000 | |
| Filed 2020-01-06 08:07 Tx date 2019-12-31 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+114,000 vol |
464,000 | |
| Filed 2020-01-06 08:04 Tx date 2019-12-31 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
16 - Acquisition or disposition under a prospectus exemption
|
$
+$57,000 vol $1,000 each |
$232,000 | |
| Filed 2020-01-02 07:59 Tx date 2019-12-31 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$95.00
+1,000 vol $0.095 each |
553,500 | |
| Filed 2019-12-28 06:55 Tx date 2019-12-24 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,820
+8,000 vol $0.4775 each |
1,575,555 | |
| Filed 2019-12-26 07:47 Tx date 2019-12-23 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,250
+10,000 vol $0.425 each |
1,567,555 | |
| Filed 2019-12-20 12:26 Tx date 2019-12-19 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,975
+5,000 vol $0.395 each |
1,557,555 | |
| Filed 2019-12-16 17:21 Tx date 2019-12-16 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,500
+10,000 vol $0.35 each |
1,552,555 | |
| Filed 2019-12-13 12:13 Tx date 2019-12-12 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$480.00
+1,500 vol $0.32 each |
1,542,555 | |
| Filed 2019-12-13 12:12 Tx date 2019-12-11 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,239
+15,000 vol $0.2826 each |
1,541,055 | |
| Filed 2019-12-05 17:10 Tx date 2019-12-05 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$2,925
+10,000 vol $0.2925 each |
1,526,055 | |
| Filed 2019-12-05 17:09 Tx date 2019-12-04 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,450
+5,000 vol $0.29 each |
1,516,055 | |
| Filed 2019-12-05 17:08 Tx date 2019-12-05 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,425
+10,000 vol $0.2425 each |
705,000 | |
| Filed 2019-12-03 15:32 Tx date 2019-12-02 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$10,000
+200,000 vol $0.05 each |
452,500 | |
| Filed 2019-12-03 15:31 Tx date 2019-12-03 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$5,000
+100,000 vol $0.05 each |
552,500 | |
| Filed 2019-12-02 16:14 Tx date 2019-12-02 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$10,000
+200,000 vol $0.05 each |
||
| Filed 2019-12-02 16:14 Tx date 2019-12-02 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$10,000
+200,000 vol $0.05 each |
452,500 | |
| Filed 2019-12-02 14:17 Tx date 2019-11-28 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$17,750
+71,000 vol $0.25 each |
1,511,055 | |
| Filed 2019-12-02 14:16 Tx date 2019-11-28 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,840
+38,000 vol $0.18 each |
695,000 | |
| Filed 2019-10-23 11:11 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
16 - Acquisition or disposition under a prospectus exemption
|
$
+$175,000 vol $0.30 each |
$175,000 | |
| Filed 2019-10-23 11:01 Tx date 2019-10-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$25,000
+100,000 vol $0.25 each |
100,000 | |
| Filed 2019-10-23 08:26 Tx date 2019-10-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$20,000
+100,000 vol $0.20 each |
||
| Filed 2019-10-23 08:26 Tx date 2019-10-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$20,000
+100,000 vol $0.20 each |
100,000 | |
| Filed 2019-10-23 08:25 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-11 11:55 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
10 - Acquisition or disposition in the public market
|
$
+$175 vol $1,000 each |
||
| Filed 2019-10-22 17:42 Tx date 2019-10-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,400
+22,000 vol $0.20 each |
100,000 | |
| Filed 2019-10-18 13:49 Tx date 2019-10-16 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,600
+78,000 vol $0.20 each |
78,000 | |
| Filed 2019-10-18 13:48 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Holder: Chantal Bourgoing (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-11 12:00 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
+350,000 vol |
350,000 | |
| Filed 2019-10-11 11:57 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-11 11:55 Tx date 2019-10-08 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
10 - Acquisition or disposition in the public market
|
$
+$175 vol $1,000 each |
$175 | |
| Filed 2019-10-11 11:47 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 10%, 2 years, $0.30 Conversion Price
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-01 15:41 Tx date 2019-10-01 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,024
+11,500 vol $0.35 each |
1,440,055 | |
| Filed 2019-09-27 07:42 Tx date 2019-09-26 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$162.50
+500 vol $0.325 each |
657,000 | |
| Filed 2019-09-27 07:41 Tx date 2019-09-26 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$312.50
+1,000 vol $0.3125 each |
1,428,555 | |
| Filed 2019-09-25 08:51 Tx date 2019-09-19 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$2,800
+56,000 vol $0.05 each |
252,500 | |
| Filed 2019-09-20 08:00 Tx date 2019-09-19 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$70.00
+1,000 vol $0.07 each |
196,500 | |
| Filed 2019-09-18 13:38 Tx date 2019-09-18 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$46,398
+148,000 vol $0.3135 each |
1,427,555 | |
| Filed 2019-09-18 13:37 Tx date 2019-09-17 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,624
+12,500 vol $0.29 each |
1,279,555 | |
| Filed 2019-09-18 13:36 Tx date 2019-09-16 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$11,455
+39,500 vol $0.29 each |
1,267,055 | |
| Filed 2019-09-18 13:35 Tx date 2019-09-16 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$150.00
+1,500 vol $0.10 each |
195,500 | |
| Filed 2019-09-12 17:22 Tx date 2019-09-12 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$3,430
+49,000 vol $0.07 each |
194,000 | |
| Filed 2019-09-12 17:21 Tx date 2019-09-12 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$1,250
+25,000 vol $0.05 each |
145,000 | |
| Filed 2019-09-04 07:38 Tx date 2019-09-03 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$290.00
+1,000 vol $0.29 each |
656,500 | |
| Filed 2019-09-04 07:37 Tx date 2019-09-03 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,709
+6,000 vol $0.285 each |
655,500 | |
| Filed 2019-08-29 16:40 Tx date 2019-08-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$6,090
+21,000 vol $0.29 each |
1,227,555 | |
| Filed 2019-08-22 11:41 Tx date 2019-08-22 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,500
+10,000 vol $0.35 each |
1,206,555 | |
| Filed 2019-08-21 17:21 Tx date 2019-08-21 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$680.00
+2,000 vol $0.34 each |
1,196,555 | |
| Filed 2019-08-21 17:20 Tx date 2019-08-21 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$8,250
+25,000 vol $0.33 each |
1,194,555 | |
| Filed 2019-08-19 10:47 Tx date 2019-08-15 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,200
+10,000 vol $0.22 each |
649,500 | |
| Filed 2019-08-14 07:31 Tx date 2019-08-13 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,000
+50,000 vol $0.24 each |
639,500 | |
| Filed 2019-07-25 14:47 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$60,000
+120,000 vol $0.50 each |
120,000 | |
| Filed 2019-07-25 14:45 Tx date 2018-12-27 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-25 14:44 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
15 - Acquisition or disposition under a prospectus
|
$60,000
+120,000 vol $0.50 each |
1,169,555 | |
| Filed 2019-07-25 11:29 Tx date 2019-07-25 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$3,000
+7,500 vol $0.40 each |
1,049,555 | |
| Filed 2019-07-25 11:28 Tx date 2019-07-24 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$4,950
+11,000 vol $0.45 each |
1,042,055 | |
| Filed 2019-07-25 11:27 Tx date 2019-07-24 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$460.00
+1,000 vol $0.46 each |
1,031,055 | |
| Filed 2019-06-25 06:38 Tx date 2019-06-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,697
+25,000 vol $0.3079 each |
589,500 | |
| Filed 2019-03-20 Tx date 2019-03-20 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
36 - Conversion or exchange
|
$22.00
+55 vol $0.40 each |
1,030,055 | |
| Filed 2019-03-05 Tx date 2019-03-01 |
$VPH
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$700.00
+1,000 vol $0.70 each |
1,030,000 | |
| Filed 2019-02-22 Tx date 2019-02-22 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$1,440
+2,000 vol $0.72 each |
1,029,000 | |
| Filed 2019-02-22 Tx date 2019-02-22 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$695.00
+1,000 vol $0.69 each |
1,027,000 | |
| Filed 2019-02-22 Tx date 2019-02-20 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
10 - Acquisition or disposition in the public market
|
$650.00
+1,000 vol $0.65 each |
1,026,000 | |
| Filed 2019-02-20 Tx date 2019-02-15 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
36 - Conversion or exchange
|
$
-$150,000 vol $0.40 each |
$0 | |
| Filed 2019-02-20 Tx date 2019-02-15 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
36 - Conversion or exchange
|
$
-$150 vol $0.40 each |
||
| Filed 2019-02-20 Tx date 2019-02-15 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
15 - Acquisition or disposition under a prospectus
|
$
+$150,000 vol $0.40 each |
$150,000 | |
| Filed 2019-02-20 Tx date 2019-02-15 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
15 - Acquisition or disposition under a prospectus
|
$
+$150 vol $0.40 each |
||
| Filed 2019-02-19 Tx date 2019-02-15 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
36 - Conversion or exchange
|
$150,000
+375,000 vol $0.40 each |
1,025,000 | |
| Filed 2019-02-19 Tx date 2019-02-15 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
15 - Acquisition or disposition under a prospectus
|
$
+$150 vol $0.40 each |
$150 | |
| Filed 2019-02-19 Tx date 2018-12-27 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-02-19 Tx date 2019-02-15 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures Class A Shares ($1000) ($0,40 conversion price)
36 - Conversion or exchange
|
$
-$150 vol $0.40 each |
$0 | |
| Filed 2019-02-18 Tx date 2019-02-15 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,119
+3,000 vol $0.3733 each |
564,500 | |
| Filed 2019-02-18 Tx date 2019-02-15 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,079
+10,000 vol $0.408 each |
561,500 | |
| Filed 2019-02-14 Tx date 2019-02-13 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,485
+5,000 vol $0.297 each |
523,000 | |
| Filed 2019-02-14 Tx date 2019-02-14 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,955
+28,500 vol $0.3493 each |
551,500 | |
| Filed 2019-01-06 Tx date 2018-12-27 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
975,000 | ||
| Filed 2019-01-05 Tx date 2018-12-27 |
$
VALEO PHARMA INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
650,000 | ||
| Filed 2018-12-27 Tx date 2018-12-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,100
+37,000 vol $0.30 each |
514,000 | |
| Filed 2018-12-27 Tx date 2018-12-21 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$290.00
+1,000 vol $0.29 each |
518,000 | |
| Filed 2018-12-27 Tx date 2018-12-19 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$840.00
+3,000 vol $0.28 each |
517,000 | |
| Filed 2018-12-19 Tx date 2018-12-17 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,080
+4,000 vol $0.27 each |
475,000 | |
| Filed 2018-12-19 Tx date 2018-12-14 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,360
+14,000 vol $0.24 each |
460,000 | |
| Filed 2018-12-19 Tx date 2018-12-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$560.00
+2,000 vol $0.28 each |
477,000 | |
| Filed 2018-12-19 Tx date 2018-12-14 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,640
+11,000 vol $0.24 each |
471,000 | |
| Filed 2018-12-11 Tx date 2018-12-06 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,270
+25,000 vol $0.2108 each |
395,000 | |
| Filed 2018-12-11 Tx date 2018-12-06 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$280.00
+1,000 vol $0.28 each |
446,000 | |
| Filed 2018-12-11 Tx date 2018-12-06 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,895
+50,000 vol $0.2179 each |
445,000 | |
| Filed 2018-09-28 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
370,000 | ||
| Filed 2018-09-28 Tx date 2018-09-18 |
$ORTH
ORTHO REGENERATIVE TECHNOLOGIES INC. |
Mainville, Luc
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
465,000 | ||
| Filed 2018-03-26 Tx date 2018-03-23 |
$ASP
Acerus Pharmaceuticals Corporation |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
1,075,000 | |
| Filed 2018-03-26 Tx date 2018-03-23 |
$ASP
Acerus Pharmaceuticals Corporation |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,175,000 | |
| Filed 2017-12-27 Tx date 2017-12-27 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,324
+50,000 vol $0.2865 each |
3,002,100 | |
| Filed 2017-12-27 Tx date 2017-12-27 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,339
+27,900 vol $0.2989 each |
3,030,000 | |
| Filed 2017-11-20 Tx date 2017-11-15 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$300.00
+2,000 vol $0.15 each |
2,947,000 | |
| Filed 2017-11-20 Tx date 2017-11-17 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$918.00
+5,100 vol $0.18 each |
2,952,100 | |
| Filed 2017-11-13 Tx date 2017-11-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,135
+139,500 vol $0.13 each |
2,848,000 | |
| Filed 2017-11-13 Tx date 2017-11-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,095
+97,000 vol $0.135 each |
2,945,000 | |
| Filed 2017-11-13 Tx date 2017-11-09 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+500,000 vol $0.12 each |
800,000 | |
| Filed 2017-11-13 Tx date 2017-11-09 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+200,000 vol $0.12 each |
1,000,000 | |
| Filed 2017-11-13 Tx date 2017-11-09 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$62,500
+500,000 vol $0.125 each |
2,695,000 | |
| Filed 2017-11-13 Tx date 2017-11-09 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,620
+13,500 vol $0.12 each |
2,708,500 | |
| Filed 2017-03-13 Tx date 2017-03-10 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
300,000 | |
| Filed 2016-12-08 Tx date 2016-12-06 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,875
+95,000 vol $0.125 each |
2,195,000 | |
| Filed 2016-11-14 Tx date 2016-11-14 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,000
+100,000 vol $0.13 each |
2,100,000 | |
| Filed 2016-08-17 Tx date 2016-08-16 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$90,000
+1,000,000 vol $0.09 each |
2,000,000 | |
| Filed 2016-08-12 Tx date 2016-07-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-12 Tx date 2016-08-11 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2016-07-27 Tx date 2016-07-21 |
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation) |
Mainville, Luc
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 |